Latest Research
Catalyst Watch: Option Players Position for Replimune Cancer Drug Approval
Replimune (REPL) options positioning recently caught my eye as 5500 May $5 puts sold to open on 4/9 and 5000 August $10 ITM puts sold to open on 4/1 $2.45 down to $2.30. On 4/2 the August $12.50 calls sold to open 12,000X in spreads with the $7.50 puts bought 12,000X,...
Small Cap Biotech Draws Massive Call Buy as Possible Takeout Bet
Biohaven (BHVN) is a small cap that saw a massive trade to close last week as 10,000 May $20 calls bought at $3 to $3.30 with shares -45% YTD but managed to close the week strong out of a base and above a rising 8-MA. BHVN is also a name that has seen size buys from...
Small Cap Pain Management Company Attractive on Valuation
Pacira (PCRX) authorized a $300M buyback Thursday after the close as a $1.14B company and has quietly been a strong 2025 performer with shares +30% YTD. PCRX traded to $80 in 2022 and in 2024 as low as $11 with shares currently forming a multi-week bull flag on the...
OptionsHawk Market Recap 4-17-2025
Bulls See Further Upside in Low Beta Grocer Amid Inflation Fears
Large Call Buyer Sticks with Biotech Growth Name Showing Relative Strength
Hawk Market Blitz 4-17-2025
Small Cap Southern Regional Bank Sees Insider Buying
Insider Spotlight FB Financial (FBK) saw a rare insider buy on 4/16 from a director who bought 7200 shares at $40.49 totaling about $292K in stock and increased his stake by +13%. This is the first insider purchase for the name since May 2023 and comes after the...
Relative Strength Restaurant Name Forming Bullish Consolidation
Brinker (EAT) shares of the restaurant chain of franchises are setting up bullish in a nice consolidation pattern that has held up great in a weak market and did not even test its rising 200 day EMA the past few weeks in the turmoil. Relative strength names like EAT...